Related Experiment Video
Updated: Aug 10, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration
He Zhang1, Zhefan Xie2, Yongming Peng1
1Department of Preventive Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, PR China; Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, PR China.
Abstract:
Rotenone, a widely used pesticide, causes dopaminergic neurons loss and increase the risk of Parkinson's disease (PD). However, few studies link the role of PARP1 to neuroinflammatory response and autophagy dysfunction in rotenone-induced neurodegeneration. Here, we identified that PARP1 overactivation caused by rotenone led to autophagy dysfunction and NLRP3-mediated inflammation. Further results showed that PARP1 inhibition could reduce NLRP3-mediated inflammation, which was effectively eliminated by TFEB knockdown. Moreover, PARP1 poly(ADP-ribosyl)ated TFEB that reduced autophagy. Of note, PARP1 inhibition could rescue rotenone-induced dopaminergic neurons loss. Overall, our study revealed that PARP1 blocks autophagy through poly (ADP-ribosyl)ating TFEB and inhibited NLRP3 degradation, which suggests that intervention of PARP1-TFEB-NLRP3 signaling can be a new treatment strategy for rotenone-induced neurodegeneration.
Insights
PARP1 overactivation by the pesticide rotenone impairs autophagy and triggers inflammation, increasing Parkinson's disease risk. Inhibiting PARP1 protects neurons by restoring autophagy and reducing inflammation.
Area of Science:
- Neuroscience
- Toxicology
- Molecular Biology
Background:
- Rotenone pesticide exposure is linked to dopaminergic neuron loss and Parkinson's disease (PD).
- The roles of PARP1, neuroinflammation, and autophagy dysfunction in rotenone-induced neurodegeneration are not fully understood.
Purpose of the Study:
- To investigate the role of PARP1 in rotenone-induced neuroinflammation and autophagy dysfunction.
- To explore the potential of PARP1 inhibition as a therapeutic strategy for rotenone-induced neurodegeneration.
Main Methods:
- Utilized rotenone models to induce neurodegeneration.
- Assessed the impact of PARP1 activation and inhibition on autophagy and NLRP3-mediated inflammation.
- Investigated the interaction between PARP1 and TFEB (Transcription Factor EB).
Main Results:
- Rotenone exposure led to PARP1 overactivation, causing autophagy dysfunction and NLRP3-driven inflammation.
- PARP1 inhibition reduced NLRP3 inflammation, an effect dependent on TFEB.
- PARP1 poly(ADP-ribosyl)ated TFEB, inhibiting autophagy and promoting neuroinflammation.
- PARP1 inhibition rescued rotenone-induced dopaminergic neuron loss.
Conclusions:
- PARP1 exacerbates rotenone-induced neurodegeneration by inhibiting autophagy via TFEB poly(ADP-ribosyl)ation and promoting NLRP3 inflammation.
- Targeting the PARP1-TFEB-NLRP3 signaling pathway presents a promising therapeutic avenue for Parkinson's disease and related neurodegenerative conditions.
More Related Videos
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
Export of Misfolded Proteins out of the ER
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...